N 739 150 (Mexiletine 150 mg)

Pill imprint N 739 150 has been identified as Mexiletine hydrochloride 150 mg.

Mexiletine is used in the treatment of myotonia congenita; ventricular tachycardia; diabetic peripheral neuropathy; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for N 739 150

Mexiletine hydrochloride 150 mg N 739 150
Mexiletine hydrochloride 150 mg N 739 150 Front
Mexiletine hydrochloride 150 mg N 739 150 Back
Mexiletine hydrochloride
Imprint:
N 739
150
Strength:
150 mg
Color:
Tan / Orange
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-8739
Inactive Ingredients:
silicon dioxide
magnesium stearate
corn starch
FD&C Yellow No. 6
gelatin
titanium dioxide
D&C Red No. 28
FD&C Blue No. 1
ammonia
ferrosoferric oxide
D&C Yellow No. 10
alcohol
FD&C Blue No. 2
FD&C Red No. 40
isopropyl alcohol
butyl alcohol
propylene glycol
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55045-3634 Dispensing Solutions Inc. (repackager)
49999-0916 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)